These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34140400)

  • 1. Self-Reported Medication Use and Urinary Drug Metabolites in the German Chronic Kidney Disease (GCKD) Study.
    Kotsis F; Schultheiss UT; Wuttke M; Schlosser P; Mielke J; Becker MS; Oefner PJ; Karoly ED; Mohney RP; Eckardt KU; Sekula P; Köttgen A;
    J Am Soc Nephrol; 2021 Sep; 32(9):2315-2329. PubMed ID: 34140400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.
    Sutherland JJ; Morrison RD; McNaughton CD; Daly TM; Milne SB; Daniels JS; Ryan TP
    JAMA Netw Open; 2018 Nov; 1(7):e184196. PubMed ID: 30646345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
    J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study.
    Mielke N; Huscher D; Douros A; Ebert N; Gaedeke J; van der Giet M; Kuhlmann MK; Martus P; Schaeffner E
    BMC Geriatr; 2020 Jan; 20(1):22. PubMed ID: 31964342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study.
    Schmidt IM; Hübner S; Nadal J; Titze S; Schmid M; Bärthlein B; Schlieper G; Dienemann T; Schultheiss UT; Meiselbach H; Köttgen A; Flöge J; Busch M; Kreutz R; Kielstein JT; Eckardt KU
    Clin Kidney J; 2019 Oct; 12(5):663-672. PubMed ID: 31584562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported Medication Adherence and Adverse Patient Safety Events in CKD.
    Hsu KL; Fink JC; Ginsberg JS; Yoffe M; Zhan M; Fink W; Woods CM; Diamantidis CJ
    Am J Kidney Dis; 2015 Oct; 66(4):621-9. PubMed ID: 25979348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study.
    Jing J; Kielstein JT; Schultheiss UT; Sitter T; Titze SI; Schaeffner ES; McAdams-DeMarco M; Kronenberg F; Eckardt KU; Köttgen A;
    Nephrol Dial Transplant; 2015 Apr; 30(4):613-21. PubMed ID: 25395390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascertainment of self-reported prescription medication use compared with pharmaceutical claims data.
    Gnjidic D; Du W; Pearson SA; Hilmer SN; Banks E
    Public Health Res Pract; 2017 Oct; 27(4):. PubMed ID: 29114718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
    Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
    Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease.
    Roux-Marson C; Baranski JB; Fafin C; Exterman G; Vigneau C; Couchoud C; Moranne O; Investigators PSPA
    BMC Geriatr; 2020 Mar; 20(1):87. PubMed ID: 32131742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing patterns of medicines in chronic kidney disease patients on maintenance hemodialysis.
    Chakraborty S; Ghosh S; Banerjea A; De RR; Hazra A; Mandal SK
    Indian J Pharmacol; 2016; 48(5):586-590. PubMed ID: 27721548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease.
    Chen DQ; Cao G; Chen H; Liu D; Su W; Yu XY; Vaziri ND; Liu XH; Bai X; Zhang L; Zhao YY
    Redox Biol; 2017 Aug; 12():505-521. PubMed ID: 28343144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication treatment complexity and adherence in children with CKD.
    Blydt-Hansen TD; Pierce CB; Cai Y; Samsonov D; Massengill S; Moxey-Mims M; Warady BA; Furth SL
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):247-54. PubMed ID: 24262500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney disease risk factors associate with urine biomarkers concentrations in HIV-positive persons; a cross-sectional study.
    Muiru AN; Shlipak MG; Scherzer R; Zhang WR; Ascher SB; Jotwani V; Grunfeld C; Parikh CR; Ng D; Palella FJ; Ho K; Kassaye S; Sharma A; Cohen M; Wang R; Qi Q; Estrella MM
    BMC Nephrol; 2019 Jan; 20(1):4. PubMed ID: 30606136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of drug use and polypharmacy burden in chronic kidney disease patients: An experience from a secondary care hospital in United Arab Emirates.
    Shouqair TM; Rabbani SA; Kurian MT
    Int J Clin Pharmacol Ther; 2021 Jul; 59(7):519-529. PubMed ID: 33835017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of urine urea nitrogen and protein intake adjusted by using the estimated urine creatinine excretion rate on the antiproteinuric effect of angiotensin II type I receptor blockers.
    Chin HJ; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Kim S; Lim CS
    Nutrition; 2015; 31(11-12):1333-8. PubMed ID: 26304595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of adherence to therapy in patients of chronic kidney disease.
    Sontakke S; Budania R; Bajait C; Jaiswal K; Pimpalkhute S
    Indian J Pharmacol; 2015; 47(6):668-71. PubMed ID: 26729961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Polypharmacy with Kidney Disease Progression in Adults with CKD.
    Kimura H; Tanaka K; Saito H; Iwasaki T; Oda A; Watanabe S; Kanno M; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1797-1804. PubMed ID: 34782408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort.
    Titze S; Schmid M; Köttgen A; Busch M; Floege J; Wanner C; Kronenberg F; Eckardt KU;
    Nephrol Dial Transplant; 2015 Mar; 30(3):441-51. PubMed ID: 25271006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.